📋 Tender Overview
Deuterium Labeling Of Glucose Improves Magnetic Resonance Imaging Sensitivity To Cancer Metabolism
Deuterium Labelling To Enhance Magnetic Resonance Imaging Specificity And Sensitivity In Cancer Diagnosticspositron Emission Tomography (Pet) Is The Only Established Technology For Whole-Body Molecular Imaging Which Is Widely Used In Cancer Diagnostics And Treatment Assessment. However, The Pet Procedure Is Expensive, Involves Ionising Radiation, And Has Limited Specificity For Cancer-Associated Glucose Uptake. The Erc-Funded Gluco-Scan Project Aims To Develop And Evaluate A Whole-Body Magnetic Resonance Imaging (Mri) Concept Such As Deuterium Metabolic Imaging (Dmi) To Overcome The Limitations Associated With The Current Pet. The Approach Will Combine Innovative Mri Hardware, Dynamic Spectroscopic Data Sampling, And Deep Learning Algorithms To Create A New Generation Of Whole-Body Scanners With The Imaging Capability Of Capturing Morphologic And Molecular Information Simultaneously.
Funded Under
European Research Council (Erc)
Total Cost
€ 2 495 924,00
Eu Contribution
€ 2 495 924,00
Coordinated By
Medizinische Universitaet Wien
Austria
